Namocatcat, Ar-ar .

HRN: 27-35-97  Sex: Male

Patient Encounter


Audit Details

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
06/24/2025
CEFUROXIME 750MG (VIAL)
06/24/2025
07/01/2025
IV
250mg
Q8h
AGE With Mod DHN
Checking Initial Appropriateness 

 Indication:  Empiric    Type of Infection:  Bloodstream    Compliance to guidelines: Compliant To Guidelines